content

canSERV, EU Cluster Effort, Offers Cancer Study In Europe

Brussels marks the beginning of the European canSERV initiative, which aims to defragment the European cancer research landscape. CanSERV will give academia and business...

WHO Strongly Advises Against The Use of 2 COVID Therapies

The World Health Organization (WHO) has discontinued the use of two COVID-19 antibody treatments on the grounds that Omicron and the variant's most recent...

Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and...

Day 1- CONNECT IN PHARMA, Geneva, Switzerland

Happiness can never be stalled, and that was pretty evident on Day 1 of Connect in Pharma. To advance innovation in a cooperative setting,...

Despite Rising Illness, Cambodian Pharma Sees Less Potential

Despite the increased prevalence of both communicable and non-communicable diseases in the nation, the commercial potential for medication manufacturers in Cambodia will remain restricted,...

Hemophilia Gene Cures From BioMarin, CSL Win ICER Support

Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their illness, even with a...

WHO Demands More Study On People Living With Long COVID

The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously. At least 17 million...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read